Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jane Huang
Age : 48
Public asset : 4,197,612 USD
Country of residence : Unknown
Linked companies : Prelude Therapeutics Incorporated - Protara Therapeutics, Inc.

Biography of Jane Huang 
Dr. Jane E. Huang, MD, is a Chief Medical Officer-Hematology at BeiGene Ltd. Dr. Huang was previously employed as a Vice President & Head-Clinical Development by Acerta Pharma BV and a Group Medical Director by Genentech, Inc. She received her undergraduate degree from Stanford University and a doctorate degree from Washington University School of Medicine.


Current positions of Jane Huang 
Holdings of Jane Huang 
Jane Huang : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/02ELON MUSK : Musk seeks to put in less money in new Twitter deal financing -sources
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/03Stocks rise, U.S. yields slip as markets await Fed rate hike
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/03ELON MUSK : Elon Musk plans to take Twitter public again later - WSJ
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
More news


© 2022 People and Ownership :   
Jane Huang : Connections 


Latest news about Jane Huang 
03/17TRANSCRIPT : Prelude Therapeutics Incorporated Presents at Barclays Global Healthcare Conference 2022, Mar-17-2022 09:00 AM
CI
03/09Prelude Therapeutics Incorporated Appoints Jane Huang as President and Chief Medical Officer, Effective April 4, 2022
CI
03/07TRANSCRIPT : BeiGene, Ltd. Presents at 42nd Annual Cowen Health Care Conference, Mar-07-2022 09:50 AM
CI
03/03BeiGene, Ltd. Announces Resignation of Jane Huang, Chief Medical Officer
CI
01/28PLURIBUS TECHNOLOGIES CORP. (TSXV : PLRB) completed the acquisition of Kesson Group.
CI
01/25PLURIBUS TECHNOLOGIES CORP. (TSXV : PLRB) agreed to acquire Kesson Group for CAD 11.6 million.
CI
2021INSIDER SELL : Beigene
MT
More news